JP2024507693A5 - - Google Patents
Info
- Publication number
- JP2024507693A5 JP2024507693A5 JP2023545974A JP2023545974A JP2024507693A5 JP 2024507693 A5 JP2024507693 A5 JP 2024507693A5 JP 2023545974 A JP2023545974 A JP 2023545974A JP 2023545974 A JP2023545974 A JP 2023545974A JP 2024507693 A5 JP2024507693 A5 JP 2024507693A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- amino acid
- terminus
- bispecific antibody
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110178932 | 2021-02-07 | ||
| CN202110178932.5 | 2021-02-07 | ||
| CN202110937430.6 | 2021-08-16 | ||
| CN202110937430 | 2021-08-16 | ||
| PCT/CN2022/074133 WO2022166728A1 (zh) | 2021-02-07 | 2022-01-27 | 双特异性抗体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507693A JP2024507693A (ja) | 2024-02-21 |
| JP2024507693A5 true JP2024507693A5 (https=) | 2025-02-03 |
Family
ID=82740913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023545974A Pending JP2024507693A (ja) | 2021-02-07 | 2022-01-27 | 二重特異性抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240092899A1 (https=) |
| EP (1) | EP4303231A4 (https=) |
| JP (1) | JP2024507693A (https=) |
| KR (1) | KR20230141817A (https=) |
| CN (2) | CN118063620A (https=) |
| AU (1) | AU2022215712A1 (https=) |
| BR (1) | BR112023015217A2 (https=) |
| CA (1) | CA3210307A1 (https=) |
| IL (1) | IL304800A (https=) |
| MX (1) | MX2023008966A (https=) |
| TW (1) | TW202233694A (https=) |
| WO (1) | WO2022166728A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL319262A (en) * | 2018-12-24 | 2025-04-01 | Sanofi Sa | Multispecific FAB pseudoproteins bind |
| JP2024534976A (ja) * | 2021-09-08 | 2024-09-26 | ジョイント・ストック・カンパニー “バイオキャド” | Ｍｈｃタンパク質に基づくヘテロ二量体を含む二重特異性抗体 |
| CN118076644A (zh) * | 2021-09-30 | 2024-05-24 | 正大天晴药业集团股份有限公司 | 针对免疫检查点的双特异性抗体 |
| CN120344558A (zh) * | 2022-12-08 | 2025-07-18 | 上海星赛生物科技有限公司 | 双特异性/多特异性抗体及其用途 |
| WO2025213057A1 (en) * | 2024-04-04 | 2025-10-09 | Fletcher Biosciences, Inc. | Engineered major histocompatibility complex molecules and uses thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE517914T1 (de) * | 2004-03-08 | 2011-08-15 | Zymogenetics Inc | Dimere fusionsproteine und materialien und verfahren zu deren herstellung |
| WO2014096015A1 (en) * | 2012-12-21 | 2014-06-26 | F. Hoffmann-La Roche Ag | Disulfide-linked multivalent mhc class i comprising multi-function proteins |
| KR102476226B1 (ko) | 2014-08-05 | 2022-12-12 | 아폴로믹스 인코포레이티드 | 항-pd-l1 항체 |
| CA3014466A1 (en) * | 2016-03-03 | 2017-09-08 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| WO2018220216A1 (en) * | 2017-06-01 | 2018-12-06 | Universität Stuttgart | Heterodimerizing ig domains |
| AU2018290272A1 (en) * | 2017-06-21 | 2020-01-30 | Gsbio, Llc | Heterodimeric bispecific antibodies |
| CN109422811A (zh) | 2017-08-29 | 2019-03-05 | 信达生物制药(苏州)有限公司 | 抗cd47抗体及其用途 |
| AU2018334886B2 (en) * | 2017-09-22 | 2025-06-26 | WuXi Biologics Ireland Limited | Novel bispecific polypeptide complexes |
| AU2018414456B2 (en) * | 2018-03-22 | 2025-09-11 | Universität Stuttgart | Multivalent binding molecules |
| WO2019195535A1 (en) | 2018-04-05 | 2019-10-10 | Novartis Ag | Trispecific binding molecules against cancers and uses thereof |
| CN112384243A (zh) * | 2018-04-17 | 2021-02-19 | 英温拉公司 | 三价三特异性抗体构建体 |
| JP2022536581A (ja) * | 2019-06-19 | 2022-08-18 | キュー バイオファーマ， インコーポレイテッド | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
-
2022
- 2022-01-27 MX MX2023008966A patent/MX2023008966A/es unknown
- 2022-01-27 BR BR112023015217A patent/BR112023015217A2/pt unknown
- 2022-01-27 WO PCT/CN2022/074133 patent/WO2022166728A1/zh not_active Ceased
- 2022-01-27 CN CN202410201902.5A patent/CN118063620A/zh active Pending
- 2022-01-27 KR KR1020237029391A patent/KR20230141817A/ko active Pending
- 2022-01-27 AU AU2022215712A patent/AU2022215712A1/en active Pending
- 2022-01-27 CN CN202280012964.0A patent/CN116964084A/zh active Pending
- 2022-01-27 JP JP2023545974A patent/JP2024507693A/ja active Pending
- 2022-01-27 US US18/275,142 patent/US20240092899A1/en active Pending
- 2022-01-27 CA CA3210307A patent/CA3210307A1/en active Pending
- 2022-01-27 EP EP22749007.5A patent/EP4303231A4/en active Pending
- 2022-01-27 TW TW111103599A patent/TW202233694A/zh unknown
-
2023
- 2023-07-27 IL IL304800A patent/IL304800A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10982008B2 (en) | Domain-exchanged antibody | |
| EP4303231A1 (en) | Bispecific antibody | |
| JP7600327B2 (ja) | Ｐｄ－１とｖｅｇｆを標的とした四価二重特異性抗体、その製造方法および用途 | |
| JP2024507693A5 (https=) | ||
| JP2016093175A (ja) | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 | |
| WO2014014796A1 (en) | Multi-specific igg-(fab)2 constructs containing t-cell receptor constant domains | |
| CN110382537B (zh) | 抗体结构域的优选配对 | |
| EP4121461A1 (en) | Miniature guidance and navigation control (minignc) antibody-like proteins and methods of making and using thereof | |
| CA3149350A1 (en) | Igm glycovariants | |
| JP2021500873A (ja) | システイン操作された抗原結合分子 | |
| TW202346337A (zh) | Ilt3及cd3結合劑以及其使用方法 | |
| KR20260010770A (ko) | 항-cd28 × 항-trop2 항체 | |
| EP4469478A1 (en) | Bispecific molecule with tunable affinity to a targetted antigen | |
| EA051713B1 (ru) | Биспецифическое антитело | |
| TWI918721B (zh) | Egfr結合複合物及其製備和使用方法 | |
| JP2025528101A (ja) | 多重特異性ポリペプチド複合体 | |
| WO2025250941A1 (en) | Cμ4 REGION FOR PAIRING HEAVY AND LIGHT CHAINS IN MULTI-SPECIFIC ANTIBODIES | |
| TW202222824A (zh) | Egfr結合複合物及其製備和使用方法 | |
| EA041608B1 (ru) | Гетеродимерный полиспецифичный формат антител |